Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding protein 12B (RBM12B) is a protein encoded by the human RBM12B gene and is characterized by the presence of an RNA recognition motif (RRM) domain, classifying it as a member of the ribonucleoprotein (RNP) superfamily[1][6][8]. The protein is predicted to bind RNA and is implicated in the regulation of RNA splicing, operating as part of ribonucleoprotein complexes within the nucleoplasm[1][4][5]. Genetic studies have associated mutations in RBM12B with rare diseases such as primary cerebellar degeneration and Boucher-Neuhauser syndrome; broader roles in gene expression and disease mechanisms may be inferred due to its fundamental involvement in post-transcriptional regulation[1][3]. There are currently no documented drug-targeting interactions, clinical biomarkers, or established therapeutic safety challenges described for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding protein 12B (RBM12B).